ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 188,49
-0,63%
Dow Jones
39 869,38
-0,10%
DAX
18 738,81
-0,72%
Brent Oil
83,135
-0,08%
Bitcoin
65 303,29
0,10%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Accuray Incorporated (ARAY)

  7. Accuray Incorporated (ARAY) Actualités

ARAY

Accuray (ARAY)

Accuray Incorporated
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ARAY
DateHeureSourceTitreSymboleSociété
10/05/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARAYAccuray Incorporated
08/05/202422h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARAYAccuray Incorporated
01/05/202422h06PR Newswire (US)Accuray Reports Fiscal 2024 Third Quarter Financial ResultsNASDAQ:ARAYAccuray Incorporated
25/04/202413h35PR Newswire (US)Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024NASDAQ:ARAYAccuray Incorporated
18/04/202413h35PR Newswire (US)Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, SwitzerlandNASDAQ:ARAYAccuray Incorporated
17/04/202422h05PR Newswire (US)Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024NASDAQ:ARAYAccuray Incorporated
26/03/202412h35PR Newswire (US)New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® SystemNASDAQ:ARAYAccuray Incorporated
05/03/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
04/03/202422h30PR Newswire (US)Accuray Incorporated to Speak at 36th Annual Roth ConferenceNASDAQ:ARAYAccuray Incorporated
27/02/202423h30PR Newswire (US)Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNASDAQ:ARAYAccuray Incorporated
13/02/202417h19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ARAYAccuray Incorporated
13/02/202413h35PR Newswire (US)Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® SystemNASDAQ:ARAYAccuray Incorporated
05/02/202423h30PR Newswire (US)Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:ARAYAccuray Incorporated
31/01/202422h06PR Newswire (US)Accuray Reports Fiscal 2024 Second Quarter Financial ResultsNASDAQ:ARAYAccuray Incorporated
25/01/202413h35PR Newswire (US)Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 SessionsNASDAQ:ARAYAccuray Incorporated
16/01/202423h30PR Newswire (US)Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024NASDAQ:ARAYAccuray Incorporated
05/12/202313h30PR Newswire (US)Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® SystemNASDAQ:ARAYAccuray Incorporated
30/11/202322h01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ARAYAccuray Incorporated
07/11/202322h07PR Newswire (US)Accuray Reports Fiscal 2024 First Quarter Financial ResultsNASDAQ:ARAYAccuray Incorporated
31/10/202312h30PR Newswire (US)Accuray to Participate in the 14th Annual Jefferies London Healthcare ConferenceNASDAQ:ARAYAccuray Incorporated
26/10/202322h05PR Newswire (US)Accuray to Report First Quarter Fiscal 2024 Financial Results on November 7, 2023NASDAQ:ARAYAccuray Incorporated
03/10/202322h05PR Newswire (US)Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products AdministrationNASDAQ:ARAYAccuray Incorporated
02/10/202313h35PR Newswire (US)Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual MeetingNASDAQ:ARAYAccuray Incorporated
29/09/202322h11Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ARAYAccuray Incorporated
29/09/202322h08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARAYAccuray Incorporated
29/09/202322h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ARAYAccuray Incorporated
18/09/202313h35PR Newswire (US)Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer CareNASDAQ:ARAYAccuray Incorporated
14/09/202313h30PR Newswire (US)Accuray to Host Investor Day at ASTRO on October 3, 2023NASDAQ:ARAYAccuray Incorporated
07/09/202322h56Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ARAYAccuray Incorporated
10/08/202302h00PR Newswire (US)Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU MarketNASDAQ:ARAYAccuray Incorporated
 Showing the most relevant articles for your search:NASDAQ:ARAY

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
EU
BEL20
Bel 20
EU
EN
Bouygues
EU
PX4
SBF 120
EU
CAP
Capgemini
USI
USTECH100
US Tech 100
FTSE
UKX
FTSE 100
SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
EU
AF
Air FranceKLM
NYSE
NKE
Nike
EU
BNP
BNP Paribas
COIN
ETHUSD
Ethereum
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés